What is the Fiscal Year for Transgene?
Date: November 14, 2026
Transgene's current fiscal year starts on March 1, 2026, and ends on February 28, 2027. Their current quarter is Q1, which ends on June 1, 2026.
Current Fiscal Year Overview
Fiscal Year Start
March 1, 2026
Fiscal Year End
February 28, 2027
Current Quarter
Q1
Current Quarter End
June 1, 2026
Quarterly Breakdown
Q1
Mar 1, 2026 – May 31, 2026
Q2
Jun 1, 2026 – Aug 31, 2026
Q3
Sep 1, 2026 – Nov 30, 2026
Q4
Dec 1, 2026 – Feb 28, 2027
Company Information
Headquarters
Illkirch-Graffenstaden, Bas-Rhin
Industry
Biotechnology
Stock Symbol
TGNA.DU
Website
https://transgene.frDescription
Cancer immunotherapy Transgene (Euronext: TNG) is a clinical-stage biotechnology company focused on individualized therapeutic vaccines
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Transgene and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.